Aprogen Medicines Inc. (KRX:007460)

South Korea flag South Korea · Delayed Price · Currency is KRW
711.00
+27.00 (3.95%)
Last updated: Jun 5, 2025
-38.97%
Market Cap 206.95B
Revenue (ttm) 138.76B
Net Income (ttm) -43.10B
Shares Out 291.07M
EPS (ttm) -159.92
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,338,025
Average Volume 1,656,712
Open 690.00
Previous Close 684.00
Day's Range 674.00 - 718.00
52-Week Range 634.00 - 1,794.00
Beta 0.41
RSI 57.30
Earnings Date May 13, 2025

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam... [Read more]

Industry Conglomerates
Sector Industrials
Founded 1971
Employees 245
Stock Exchange Korea Stock Exchange
Ticker Symbol 007460
Full Company Profile

Financial Performance

In 2024, Aprogen Medicines's revenue was 150.11 billion, a decrease of -0.31% compared to the previous year's 150.58 billion. Losses were -58.08 billion, 4.42% more than in 2023.

Financial Statements

News

There is no news available yet.